Collection of Information to Better Understand Young Onset Colorectal Cancer
Part of paid clinical trials in Basking Ridge, New Jersey.
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Study ID
- NCT04489238
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Risk Factor Questionnaire — OTHERParticipants, both cases and controls, will complete the CYOC risk factor questionnaire, preferably at the time of first visit
Study Details
The purpose of this registry study is to create a database-a collection of information-for better understanding young onset colorectal cancer. Colorectal cancer patients are considered to have young onset colorectal cancer if they are diagnosed with their cancer before the age of 50. Researchers will use the information from this database to learn more about how young onset colorectal cancer may be similar to or different from colorectal cancer that is diagnosed later in life. Researchers will also use information from the database for current and future research on young onset colorectal cancer.
Key Dates
- Start date
- Jul 22, 2020
- Status verified
- Feb 2026
- Primary completion
- Jul 22, 2026
- Completion
- Jul 22, 2026
Study Design
- Enrollment
- 1,366 participants (estimated)
Arms
- Arm: Young onset Colorectal Cancer Participants(Stool collection on newly diagnosed patients in this cohort) Participants will include patients under the age of 50 who are diagnosed with colorectal adenocarcinoma.
- Arm: Average onset Colorectal Cancer Participants(Stool collection cohort only) 166 colorectal cancer patients 50 year-old or older will serve as controls. Stool collection cohort only.
Primary Outcome Measure
Establish a prospective database of patients with Young Onset Colorectal Cancer [ Time Frame: 1 year ]
Central Contacts
- Andrea Cercek, MD646-888-4189
- Rona Yaeger, MD646-888-5109
Locations (8)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Memorial Sloan Kettering Basking Ridge (All Protocol Activities) | Basking Ridge | New Jersey | 07920 | Andrea Cercek, MD 646-888-4189 |
| Memorial Sloan Kettering Monmouth | Middletown | New Jersey | 07748 | Andrea Cercek, MD 646-888-4189 |
| Memorial Sloan Kettering Bergen | Montvale | New Jersey | 07645 | Andrea Cercek, MD 646-888-4189 |
| Memorial Sloan Kettering Cancer Center @ Commack | Commack | New York | 11725 | Andrea Cercek, MD 646-888-4189 |
| Memorial Sloan Kettering Westchester | Harrison | New York | 10604 | Andrew Cercek, MD 646-888-4189 |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | Andrew Cercek, MD 646-888-4189 |
| MSK at Ralph Lauren | New York | New York | 10035 | Andrew Cercek, MD 646-888-4189 |
| Memorial Sloan Kettering Nassau | Rockville Centre | New York | 11553 | Andrea Cercek, MD 646-888-4189 |
Find similar trials in Basking Ridge, NJ
Related Studies
- A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid TumorsPHASE1/PHASE2 · Recruiting · Merus B.V. · La Jolla, California
- Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC FusionsPHASE1/PHASE2 · Recruiting · IDEAYA Biosciences · Los Angeles, California
- Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal MetastasesPHASE1/PHASE2 · Recruiting · Roswell Park Cancer Institute · Buffalo, New York
- Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid TumorsPHASE1 · Recruiting · Bicara Therapeutics · La Jolla, California